Maxx Orthopedics Inc. has announced FDA clearance for its medial congruent insert, designed for use with the Freedom total knee arthroplasty (TKA) system. This new insert is engineered to provide enhanced medial stability and replicate the kinematics of a natural knee, potentially improving outcomes for patients undergoing TKA.
The Freedom medial congruent insert is specifically designed to match natural knee mechanics. By improving medial stability, the insert aims to address a critical factor in the success of TKA procedures. According to the company, this design philosophy reflects a commitment to continuous innovation in orthopedics.
Mimicking Natural Knee Movement
Ashesh Shah, CEO of Maxx Orthopedics, stated that the medial congruent insert expands the Freedom knee portfolio by providing a tibial insert designed to give patients knee movement, in cruciate-retaining procedures, that mimics the natural knee. This is intended to provide a more natural feeling and function for patients after surgery.
The new insert is intended for use in cruciate-retaining TKA procedures, which preserve the posterior cruciate ligament (PCL). This approach aims to maintain more natural knee kinematics compared to cruciate-sacrificing techniques, potentially leading to improved patient satisfaction and functional outcomes.
Total Knee Arthroplasty
Total knee arthroplasty is a common and effective procedure for relieving pain and restoring function in patients with severe knee arthritis. According to the CDC, over 700,000 total knee arthroplasties are performed each year in the United States. The goal of TKA is to replace the damaged joint surfaces with prosthetic components, restoring alignment and stability to the knee.
